Serial Number | 79369434 |
Word Mark | ONLY ONO |
Filing Date | Thursday, January 19, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, May 21, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 21, 2024 |
Goods and Services | Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes for treating cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; general and topical anesthetic, sedative and analgesic drugs; vaccines |
Goods and Services | Provision of medical and medical pharmaceutical information via the Internet; provision of medical information relating to medical benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; advisory services relating to pharmaceutical products; provision of information on pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic or treatment purposes; medical testing; medical consultancy and diagnosis via the Internet; online medical counseling services; remote monitoring of patient health status for medical conditions; remote monitoring of medical data for medical diagnosis and treatment; analysis and provision of clinical data of patients for medical diagnostic or treatment purposes; provision of medical information; physical examination; providing medical information about pharmaceuticals, medical services or health; consultancy services relating to medical services, pharmaceuticals, health or dispensing of medications; consultancy, advisory and provision of information relating to health care; managed health care services; provision of records of personal health information data such as weight, body fat, body temperature, number of steps, sleeping hours and blood pressure; nursing care; rental of medical apparatus and instruments |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 19, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 19, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | ONO PHARMACEUTICAL CO., LTD. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | JP |
Party Name | ONO PHARMACEUTICAL CO., LTD. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | JP |
Event Date | Event Description |
Thursday, May 11, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, May 23, 2023 | APPLICATION FILING RECEIPT MAILED |
Wednesday, May 17, 2023 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Friday, May 19, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 17, 2023 | ASSIGNED TO EXAMINER |
Thursday, October 26, 2023 | NON-FINAL ACTION WRITTEN |
Friday, October 27, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Monday, October 30, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, November 22, 2023 | REFUSAL PROCESSED BY IB |
Wednesday, April 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, April 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, April 15, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Monday, April 15, 2024 | EXAMINERS AMENDMENT E-MAILED |
Monday, April 15, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, April 15, 2024 | EXAMINER'S AMENDMENT ENTERED |
Monday, April 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 21, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, May 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Monday, October 30, 2023 | REFUSAL PROCESSED BY MPU |